JOURNEY MEDICAL CORPORATION ANNOUNCES PUBLICATION OF CLINICAL TRIAL RESULTS ASSESSING THE IMPACT OF EMROSI™ (DFD-29) ON MICROBIAL FLORA OF HEALTHY ADULTS IN THE JOURNAL OF DRUGS IN DERMATOLOGY

Reuters · 2d ago

Please log in to view news